Partnership Opportunities

Partner with the Only Industry-Dedicated Kinase Inhibitor Meeting
to Maximize your Influence

The 3rd Kinase Targeted Drug Discovery Summit is a transformative forum bringing together 100+ kinase experts from the pharmaceutical, biotechnology, and academic sectors. From target identification and lead optimization to assay development, join an engaged audience dedicated to preclinical kinase success.

Our industry’s decision-makers need your latest platforms, tools, and technologies to maximize their discovery capabilities to achieve the next generation of kinase therapies.

Current Partners:

Our Kinase Drug Developers & Researchers Need Your Help With:

  • Highly sensitive kinase assays
  • Advanced phospho-proteomic profiling platforms
  • Computational and AI drug design tools
  • Ground-breaking cryo-EM technologies

Why Partner?

With a unified goal to improve previous generations of kinase therapeutics, this is your unique opportunity to kickstart 2025 as a leading service provider.
Contribute to a modality-agnostic solution for disease indications involving dysfunctional kinases across oncology, immunology, dermatology, neurodegeneration, and more.

Don’t miss your chance to:
element 1

Enable highly sensitive assays that can screen against a comprehensive set of kinases

elements 3

Display advanced phospho-proteomic profiling platforms that can identify critical phosphorylation sites

elements 4

Spotlight computational drug design tools that can enhance predictive models of complex kinase interactions

elements 5

Present ground-breaking cryo-EM technologies that can deliver high-resolution structures of transient domains

Who Will You Meet: